Cours Beleave Inc. Canadian Securities Exchange
Actions
BE
CA0775611084
Produits pharmaceutiques
CA 2018 | - | CA 2019 | 2,37 3,25 2,12 | Capitalisation | 30,37 M 41,55 M 27,14 M |
---|---|---|---|---|---|
Résultat net 2018 | -12 M -16,42 M -10,72 M | Résultat net 2019 | -33 M -45,15 M -29,49 M | VE / CA 2018 | - |
Trésorerie nette 2018 | 5,2 M 7,12 M 4,65 M | Dette nette 2019 | 10,32 M 14,11 M 9,22 M | VE / CA 2019 | 17 137 012 x |
PER 2018 |
-4,72
x | PER 2019 |
-0,76
x | Employés | - |
Rendement 2018 * |
-
| Rendement 2019 |
-
| Flottant | 98,39% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Founder | - | 26/05/00 | |
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15/12/15 |
Kevin Keagan
BRD | Director/Board Member | - | 24/10/18 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Roger Ferreira
CTO | Chief Tech/Sci/R&D Officer | - | 15/12/15 |
Founder | - | 26/05/00 | |
Kevin Keagan
BRD | Director/Board Member | - | 24/10/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+9,94% | 4,81 Md | |
-32,21% | 3,6 Md | |
-1,43% | 3,09 Md | |
-25,09% | 2,62 Md | |
-11,46% | 2,27 Md | |
+36,65% | 1,82 Md | |
+37,15% | 1,41 Md | |
-16,01% | 1,38 Md | |
+40,95% | 1,37 Md |